Resource Library

Assessment Therapy Figures FAQs Media for Patients

Frequently Asked Questions

General

Go to the “Register” page and fill in your information. Once registered, you will be taken to the “Training” page, where you can proceed through the course at your own pace.

CBTNightmaresweb and the resulting CE credits offered upon completion of the course are completely free! Simply register to get started!

6.5 Continuing Education (CE) credits for psychologists and some other allied health and mental health professionals for the completion of this training. This program is co-sponsored with The Medical University of South Carolina’s Department of Psychiatry and Behavioral Sciences Office of Continuing Education. The Medical University of South Carolina’s Department of Psychiatry and Behavioral Sciences Office of Continuing Education is approved by the American Psychological Association to sponsor continuing education for psychologists.

The Medical University of South Carolina’s Department of Psychiatry and Behavioral Sciences Office of Continuing Education maintains responsibility for this program and its content. Credit inquiries contact: psych-events@musc.edu or +1(843)792-9113.

If you are unsure if CEs co-sponsored by the American Psychological Association are acceptable for your licensure it is best to inquire with your local board as this can vary by state/territory.

Once the course has been completed and the final post-test has been passed, you will be able to print your personalized CE certificate for your records.

CBTNightmaresweb is designed to take 6.5 hours. However, it is a self-paced training and some find it takes more time and others will take less. Once you have registered, there is a "Modules" page that tells you the amount of "Required" and “Optional” times that each module (lesson) will take.

The videos are not able to be downloaded for copyright purposes, so they must be watched from the website.

If possible, trying on a different browser (e.g., Chrome instead of Safari) and/or device (e.g., laptop instead of tablet) can help resolve some issues that are occasionally experienced. If you are unable to switch or the switch does not remedy the problem please contact us via the Contact Us page or email us at cbtnightmaresweb@musc.edu. If you let us know what browser(s) and device(s) you are using we will be able to troubleshoot further.

This training was created with clinicians in mind, and we want to make sure we make it clear that it is only designed to help clinicians be minimally proficient in CBTN. True expertise requires further consultation and supervision. That being said, we have made the training freely available because we believe everyone can benefit from the concepts taught throughout the training, so please feel free to share with others who you think would find it useful.i

CBT-N Consultation

You can sign up using this link!

(https://docs.google.com/forms/d/e/1FAIpQLScGoIPKyg_jJtyD9jIXNPOQIgcHzCoXzVvlfiIRzG_MpUD9Iw/viewform?usp=sf_link)

(For information about CBT-N Consultants, please also see Meet The Team)

Consultation is an important next step as you begin to implement CBT for Nightmares. Engaging in Consultation when practicing a new behavioral intervention ensures that providers are meeting their ethical responsibility of providing competent clinical services (Ethical Principles of Psychologists, 2.01). Our Consultants are experienced in the provision of CBT-N and can offer advice on addressing the needs of clients with co-occurring sleep and behavioral health concerns. Consultees also have the option of achieving provider status in CBT-Nightmares or may wish to count their Consultation hours towards a Diplomate in Behavioral Sleep Medicine (DBSM).

Consultees must be health or behavioral health providers who are licensed to practice independently and have completed CBT-N training prior to the start of consultation. Past experience in the provision of cognitive behavioral therapy and / or trauma intervention is beneficial to learning CBT-N, but not required.

Consultation is conducted via video teleconference in a weekly group format (typically @   4 - 8 consultees).  Groups meet for 20 sessions (approximately 5 months). Sessions last 50-55 minutes.  Some consultation groups may also include providers who are receiving consultation for CBT for Insomnia (CBT-I). We encourage consultees to make every effort to attend regularly, especially while actively seeing CBT-N cases in order to receive timely advice and support for implementing this brief intervention. See below for attendance requirements for those seeking optional provider status for CBT-N.

Yes! As part of this consultation, we are offering the option of achieving provider status in CBT-Nightmares. Provider status requirements include:

1. Complete CBT-N training

2. Attend and actively participate in a minimum of 14 Consultation sessions

3. Complete to treatment fidelity a minimum of 3 individual cases

4. A part of each main component of treatment (e.g., sleep habit review, introducing theories of nightmares, exposure, rescripting, and relaxation training) must be discussed in order for the consultant to determine that the provider has mastered the skill. Providers have the option of recording sessions for the consultant to review.

Yes, two of our Consultants (Drs. Pruiksma and Rubin) are board-certified in Behavioral Sleep Medicine. Participation in their CBT-N Consultation groups can be counted towards eligibility requirements for BSM certification. (For more information, please see Board of Behavioral Sleep Medicine website at bsmcredential.org/index.php/eligibility.)

At this time our group is unable to offer consultation for clinical cases seen within the VA.  This is for multiple reasons, including payment and technical issues. We recommend that VA providers who are interested in CBT-N consultation contact Katherine Miller (at katherine.miller13@va.gov) or VACBTNightmares@va.gov to express interest in attending CBT-N consultation through one of the VA-based CBT-N consultation groups.  While these groups have limited capacity to offer consultation beyond those who attend live (virtual or in person) training, they may be able to offer placement on their wait list.  In addition, being able to identify VA providers who are seeking consultation will hopefully lead to greater resources being given to VA-based consultation groups.

Upcoming Groups(please note times may be subject to change): 

January 2025 Thursdays 3pm CST with Dr. Joanne Davis, Ph.D. (Please note:  If interested in joining cohort offering consultation that counts towards DBSM, please contact Dr. Rubin at Rubinmiriam79@gmail.com).

Fee: $500 (approximately $25 per consultation session for 5 months). Payment can be made in full ($500) or in two installments of $250 each, made prior to the start of group and midway through the group.  Information regarding method of payment will be sent upon receipt of the CBT-Nightmare Consultation Sign-up Form (see below under “How can I sign up for or get more information about Consultation?”)

Refund Policy: Consultees who wish to withdraw from group after the initial session will be given a refund minus any payment-related fees.  After the initial session, refunds will be made at the discretion of the consultant.

You can send questions to Dr. Miriam Rubin:  Rubinmiriam79@gmail.com

 and CBTNightmares@MUSC.edu

Treatment Considerations

If a patient is taking nightmare medication but continues to have dreams that cause awakenings that they can remember and that cause clinically significant distress, then CBT-N is still appropriate. If the patient has the goal of going of nightmare medications, engage in shared decision making around if the patient will start that process with their prescriber before, during, or after CBT-N. 

Yes! As part of this consultation, we are offering the option to achieve provider status in CBT for Nightmares. Provider status requirements include:

1. Complete training

2. Attend and actively participate in a minimum of 10 calls

3. Complete to treatment fidelity a minimum of 3 individual cases, 2 groups, or a combination of both

4. A part of each main component of treatment (e.g., sleep habit review, introducing theories of nightmares, exposure, rescripting, and relaxation training must be demonstrated on a recording in order of the consultant to determine that you have mastered the skill.

Nightmares can be caused by substances and medications. The most commonly reported substance that is associated with nightmares in alcohol but nightmares can also be seen with benzodiazepines, especially when an individual stops using them and they can have a rebound in REM sleep. Some of the most common medications associated with nightmares include antidepressants (e.g., bupropion, selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors and tricyclic antidepressants), anti-hypertensive medications (e.g.,propranolol, metoprolol and verapamil); acetylcholinesterase inhibitors used for treating patients with Alzheimers or dementia (e.g. donepezil and rivastigmine), dopaminergic medications (e.g., levodopa, pramipexole, ropinirole and selegiline which are used in patients with Parkinson’s disease and antimicrobials (e.g., ciprofloxacin, erythromycin, ganciclovir and mefloquine).  

It's always a good idea to encourage our clients to speak with their prescribing provider about their medication concerns as this is outside the scope of practice for the majority of mental health professionals. It may be helpful to ask the client to complete a release of information that will enable collaboration of care.

Physical or ability differences may require adjustments in which an audio recorder is used, the provider or a support person assists in the writing activities.  Use of large print materials or a support person may help with eyesight differences.  Mobility differences may require modifications of stimulus control instructions.

It depends. The 2023 VA/DoD Treatment Guidelines for the Management of Posttraumatic Stress Disorder state that there is insufficient evidence to recommend for or against CBT-N. Currently, there is not enough research to provide evidence-based guidelines for how to proceed if a patient with frequent nightmares also meets criteria for PTSD. Treating nightmares can significantly improve PTSD, depression, and sleep (e.g., Casement & Swanson, 2012; Ho, Chan, & Tang, 2016) and evidence-based treatments for PTSD can improve sleep and nightmares (e.g., Belleville, Guay, & Marchand, 2011; Pruiksma et al., 2023; Taylor et a., 2020). However, insomnia typically remains (e.g., Pruiksma et al., 2016; Pruiksma et al., 2023; Taylor et al., 2020) and nightmares may continue (although nightmares tend to be more responsive to trauma-focused treatment than insomnia). There are pros and cons for treating PTSD or sleep first. The benefits of treating PTSD first are that this approach quickly targets the trauma directly which may also sufficiently address the sleep problems or may require fewer sleep-focused sessions afterwards. The cons of treating PTSD first is that hyperarousal symptoms may interfere with treatment because they can lead to sleep disturbances that can both impede engagement in PTSD treatment and limit the brain’s ability to process the memories and emotions during PTSD treatment. The benefits of treating sleep first are that improved sleep may improve memory consolidation, emotion processing, and coping during PTSD treatment, and treating sleep is likely to improve PTSD and depression symptoms. Furthermore, treating sleep can be thought of as a “gateway” to PTSD treatment, allowing the provider and patient to develop rapport prior to focusing directly on the trauma. The costs of treating sleep first are that it delays focus on the trauma-specific intervention, which some consider a form of colluding with avoidance. The availability of PTSD treatment is also a consideration for providers not trained in an evidence-based PTSD treatment. Given the many considerations in deciding on the order of treatments, it is important to review the case formulation and involve the patient in the process of shared decision making.

Medications can be helpful for some individuals in reducing the frequency of nightmares or reducing the memory of having nightmares; however, nightmares may return if medications are discontinued. Cognitive behavioral approaches typically result in significant reduction of the frequency and intensity of nightmares for many people.  Improvements in other symptoms [e.g., PTSD, depression, anxiety, sleep quality] are also common following cognitive behavioral approaches.

Individuals with a history of TBI may benefit from increased interaction with the manual [e.g., reading through session materials between sessions] as well as "teach back" techniques in which the provider asks questions throughout the session and the client states the material in their own words.

Shared decision making can be important in this conversation in order to problemsolve while also incorporating the patient's indivudal values and preferences. For example, is it possible for the bed partner to relocate to another room while the patient engages in nightmare treatment? 

Research shows that repeated exposure to the nightmare is not needed in order for individuals to experience a decrease the frequency and intensity of nightmares. 

If the client perpetrated an action in the course of the trauma, no changes are required to the treatment as the focus is on the nightmares, not the trauma.  If the client is a perpetrator in the nightmare, the process of the written exposure and rescription is the same.

Remind the client that nightmare exposure, rescription, even nightmare treatment in general is not trauma treatment. The rescription is to modify the nightmare, not the trauma event. Trauma treatment is available and should be discussed with clients if applicable.

Yes! CBTn is not contraindicated for patients who are at risk for suicide. Of course, suicide risk should be assessed and managed throughout any treatment (e.g., crisis response plan) and individuals at imminent risk for suicide should be linked appropriate levels of care and services. Nightmares are correlated with suicidal ideation and suicide attempts. While CBTn is not a treatment for suicide, addressing the nightmares may help to decrease the patient's distress that could be contributing to suicidal thoughts and behaviors. Of note, suicide specific treatments are available and should be offered to patients as indicated (e.g., BCBT, CBT-SP).

While wearable sleep trackers can provide insight and comfort to many people, the accuracy of the technology is still evolving.  We encourage patients to use the sleep diary and not to rely on the data provided through their wearable tracker. Additionally, if the data from the tracker is causing the patient distress (e.g., hyper focused on sleep times to the point of sleep disruption), we would encourage them to discontinue use while in treatment. 

There is no evidence to suggest that CBT-N would not be helpful or indicated for individuals who are taking medications for nightmares. Of note, if the patient at some point decides to stop taking their prescribed medication, it is not uncommon to experience a rebound effect, where the frequency and/or intensity of the nightmares worsens. Providers should discuss this with their patients and make plans to address the rebound, should it occur.

An overnight sleep study is required for a diagnosis of sleep apnea. This may be conducted in a lab or with a home sleep test. In both types of testing, a patient has their breathing evaluated for air flow, respiratory effort, heart rate and oxygen saturations. For a diagnosis of sleep apnea, a patient must stop breathing > 5 /hour. Most patients who are diagnosed with sleep apnea are prescribed a positive airway pressure machine. When the machine delivers air continuously, it’s known as a CPAP machine, while machine’s that automatically adjust to the patient’s breathing patterns are called APAP machines. For both devices, air pressure is provided to keep the airway open and prevent it from collapsing. Neither CPAP nor APAP actually breath for the patient.  

A common misconception is that sleep apnea only happens to overweight, middle-aged, and older men. While weight and male gender increase the risk for sleep apnea, men, women, and children of all shapes and sizes can have sleep apnea. Women are less likely than men to report classic symptoms of sleep apnea, such as snoring, apneas, or gasping. Instead, they may report nonspecific symptoms like headaches, fatigue, and symptoms of insomnia such as sleep disruption. Untreated sleep apnea is associated with a range of medical and mental health problems including hypertension, heart disease, depression, memory problems, and drowsiness that can increase the risk of car accidents. 

Sleep apnea can be comorbid with insomnia, nightmares, or both, especially in individuals with PTSD. The clinical picture in these patients can be quite complex. Sleep apnea therapies are very effective when used and may even reduce nightmares. However, many patients have difficulties adhering to apnea treatments for a range of reasons, including nightmares. It can be important to encourage the patient to work with their sleep clinic to overcome barriers to sleep apnea treatment adherence. In some cases, treating nightmares and insomnia may help with adherence. While you can move forward with CBT-N, patients should be aware that they may not receive the same benefit when their sleep apnea is inadequately treated.  

CBT-N can easily be implemented via telehealth, keeping in mind a few considerations. First, as with all telehealth, we want to ensure our patients are in a quiet, private space. During the nightmare exposure, we may ask the patient to remain visible so that we can monitor their presentation and engagement. We will also want to make sure the patient has access to the CBTn client workbook, sleep diary, and handouts.

There is limited research examining CBT-N among adolescents and children. However, a treatment manual has been developed and tested. 

Cromer, L., Bell, S. B., Prince, L. E., Hollman, N., El Sabbagh, E., & Buck, T. Efficacy of a telehealth cognitive behavioral therapy for improving sleep and nightmares in children aged 6-17. Frontiers in Sleep3, 1401023.

Stay tuned! We plan to add a module on treating nightmares in children and adolescents in 2025!

Some patient populations have difficulty with the instructions of stimulus control that require them to get out of bed when they are not sleepy or asleep during the night. For example, hospitalized inpatients, individuals with Parkinson's’ or other movement disorders, older adults, and individuals with chronic pain may struggle with these instructions or be unable to implement them. In this case, we recommend an alternative approach called “counter control,” which has the same goal and largely achieves the same effects as stimulus control.

In counter control, the patient is instructed to follow the same 15-minute rule of stimulus control. However, instead of getting out of bed after 15 minutes of wakefulness in bed, the patient instead changes the context of their in-bed experience. The goal is to remove sleep effort from the bed—that is, to stop trying to sleep. To achieve this, it is helpful to make some changes to the sleep environment and bed when counter control is being enacted. Depending on the patient’s individual limitations, this could mean switching on a dim light and sitting up against some pillows. Alternatively, a patient could move so that they are laying horizontally on the bed, or put their head at the opposite end than the one they typically use. It may be helpful to encourage the patient to think of two different “modes” that they can be in while in bed – either “sleep mode,” in which they are in their typical sleep position, with lights off, or in “wake mode” in which they change their situations and cues while in bed, and are NOT aiming to fall asleep. Though it may seem counterintuitive given what we prescribe in stimulus control to ask patients to engage in activities other than sleep and sex in the bed, considering the underlying rationale of stimulus control helps to resolve this paradox. We are helping the patient to associate certain cues (“sleep mode”) with sleep, and certain cues (“wake mode”) with wake. Just like in stimulus control, if the patient begins to feel sleepy while in “wake mode,” they should transition back to “sleep mode.” If unable to sleep while in “sleep mode,” they should again follow the 15-minute rule as many times as necessary.

The limited research on counter control suggests it may be equally or somewhat less effective compared to stimulus control. A 1979 study by Zwart and Lisman demonstrated among 47 undergraduates, stimulus control and counter control both experienced improved sleep to a similar extent. A study by Davies and Colleagues (1986) revealed 74% of individuals with sleep maintenance insomnia who were treated with counter control did significantly reduce their wake after sleep onset by an average of 30%. However, the authors note that this magnitude of effect is somewhat attenuated compared to their prior studies of stimulus control.

Ultimately, the choice of whether to use stimulus control or counter control will likely be dictated by the individual patient’s needs. If possible, we recommend starting with stimulus control given the stronger research based. However, if stimulus control is not possible with your patient, then the next best course of action is likely counter control.

Some patient populations have difficulty with the instructions of stimulus control that require them to get out of bed when they are not sleepy or asleep during the night. For example, hospitalized inpatients, individuals with Parkinson's’ or other movement disorders, older adults, and individuals with chronic pain may struggle with these instructions or be unable to implement them. In this case, we recommend an alternative approach called “counter control,” which has the same goal and largely achieves the same effects as stimulus control.

In counter control, the patient is instructed to follow the same 15-minute rule of stimulus control. However, instead of getting out of bed after 15 minutes of wakefulness in bed, the patient instead changes the context of their in-bed experience. The goal is to remove sleep effort from the bed—that is, to stop trying to sleep. To achieve this, it is helpful to make some changes to the sleep environment and bed when counter control is being enacted. Depending on the patient’s individual limitations, this could mean switching on a dim light and sitting up against some pillows. Alternatively, a patient could move so that they are laying horizontally on the bed, or put their head at the opposite end than the one they typically use. It may be helpful to encourage the patient to think of two different “modes” that they can be in while in bed – either “sleep mode,” in which they are in their typical sleep position, with lights off, or in “wake mode” in which they change their situations and cues while in bed, and are NOT aiming to fall asleep. Though it may seem counterintuitive given what we prescribe in stimulus control to ask patients to engage in activities other than sleep and sex in the bed, considering the underlying rationale of stimulus control helps to resolve this paradox. We are helping the patient to associate certain cues (“sleep mode”) with sleep, and certain cues (“wake mode”) with wake. Just like in stimulus control, if the patient begins to feel sleepy while in “wake mode,” they should transition back to “sleep mode.” If unable to sleep while in “sleep mode,” they should again follow the 15-minute rule as many times as necessary.

The limited research on counter control suggests it may be equally or somewhat less effective compared to stimulus control. A 1979 study by Zwart and Lisman demonstrated among 47 undergraduates, stimulus control and counter control both experienced improved sleep to a similar extent. A study by Davies and Colleagues (1986) revealed 74% of individuals with sleep maintenance insomnia who were treated with counter control did significantly reduce their wake after sleep onset by an average of 30%. However, the authors note that this magnitude of effect is somewhat attenuated compared to their prior studies of stimulus control.

Ultimately, the choice of whether to use stimulus control or counter control will likely be dictated by the individual patient’s needs. If possible, we recommend starting with stimulus control given the stronger research based. However, if stimulus control is not possible with your patient, then the next best course of action is likely counter control.

Typically, we suggest avoiding doing both treatments at the same time, due to: 1) patient burden, 2) exacerbation of sleep disturbance that may occur initially with PTSD-focused care, and 3) potential benefit on nightmares with PTSD-focused treatment. Due to the workload involved in both trauma-focused psychotherapy and CBT-N, I would consider the Veteran’s ability to do all of the homework well, without feeling overwhelmed, and how the homework assignments from both treatments may either integrate or oppose each other.  For example, the beginning stages of CBT-N may lead to initial schedule disruption with the focus on stimulus control, set schedules, etc. and the beginning stages of trauma-focused psychotherapy may also exacerbate sleep disturbance due to impact statements, initial discussions of trauma, etc.  Therefore, you may be working against each other initially, and could impact initial motivation if the Veteran does not start seeing results early on or feels overwhelmed. 

Sleep efficiency is calculated by dividing Total Sleep Time by Time in Bed.

  • Total Sleep Time is calculated as Time in Bed - Latency to Sleep - Minutes Awake in the Middle of the Night.
  • Time in Bed is the duration between Time You Tried to Go to Sleep and Out of Bed.

Website Navigation

Yes! Use the gear icon on the bottom left of the video to change the speed of the video.

This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Review Medical Research Program under Award No. W81XWH-21-1-0576 Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.